King Christian X's Rheumatism Hospital, Graasten, Denmark Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00660647
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

adalimumab (humira) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1